Literature DB >> 5027964

Chronic toxicity of adriamycin: a new antineoplastic antibiotic.

C Bertazzoli, T Chieli, G Ferni, G Ricevuti, E Solcia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5027964     DOI： 10.1016/0041-008x(72)90149-4

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  7 in total

1.  The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.

Authors:  M A Graham; D R Newell; B J Foster; A H Calvert
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Neurotoxicity and dermatotoxicity of cyanomorpholinyl adriamycin.

Authors:  S C Cramer; R H Rhodes; E M Acton; Z A Tökés
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Effect of melatonin on hyperlipidemic nephropathy under constant light exposure.

Authors:  L Túnez; M C Muñoz; A L Feijoo-López; E Valdvira; L Bujalance-Arenas; P Montilla
Journal:  J Physiol Biochem       Date:  2002-06       Impact factor: 4.158

4.  Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.

Authors:  J F Van Vleet; V J Ferrans; W E Weirich
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

5.  Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss.

Authors:  G Powis; K L Kooistra
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status.

Authors:  Vanessa Vendramini; Estela Sasso-Cerri; Sandra M Miraglia
Journal:  Reprod Biol Endocrinol       Date:  2010-01-10       Impact factor: 5.211

7.  Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin.

Authors:  Lucy Kopecny; Carrie A Palm; Katherine A Skorupski; Mikel Delgado; Robert B Rebhun
Journal:  J Vet Intern Med       Date:  2020-08-11       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.